Signaling through C/EBP homologous protein and death receptor 5 and calpain activation differentially regulate THP-1 cell maturation-dependent apoptosis induced by shiga toxin type

Infection and Immunity

Volumn 78, Issue 8, 2010, Pages 3378-3391

  Lee, Moo Seung ^a   Cherla, Rama P ^a   Lentz, Erin K ^a   Leyva Illades, Dinorah ^a   Tesh, Vernon L ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CALPAIN; CASPASE; DEATH RECEPTOR 5; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; PROTEIN BCL 2; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VEROTOXIN 1; SHIGA TOXIN; TNFSF10 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; CELL LINE; DRUG ANTAGONISM; DRUG EFFECT; GENE SILENCING; METABOLISM; MONOCYTE; PHYSIOLOGY;

APOPTOSIS; CALPAIN; CELL LINE; GENE SILENCING; HUMANS; MONOCYTES; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; SHIGA TOXIN; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSCRIPTION FACTOR CHOP;

EID: 77955284279     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00342-10     Document Type: Article

References (68)

1. Ashkenazi, A., and V. M. Dixit. 1998. Death receptors: signaling and modulation. Science 281:1305-1308.
2. Blomgren, K., C. Zhu, X. Wang, J. O. Karlsson, A. L. Leverin, B. A. Bahr, C. Mallard, and H. Hagberg. 2001. Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: a mechanism of "pathological apoptosis"? J. Biol. Chem. 276:10191-10198.
3. Chawla-Sarkar, M., S. I. Bae, F. J. Reu, B. S. Jacobs, D. J. Lindner, and E. C. Borden. 2004. Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis. Cell Death Differ. 11:915-923. (Pubitemid 39139750)
4. Cherla, R. P., S.-Y. Lee, R. A. Mulder, M.-S. Lee, and V. L. Tesh. 2009. Shiga toxin 1-induced proinflammatory cytokine production is regulated by the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling pathway. Infect. Immun. 77:3919-3931.
5. Cherla, R. P., S.-Y. Lee, and V. L. Tesh. 2003. Shiga toxins and apoptosis. FEMS Microbiol. Lett. 228:159-166.
6. Ching, J. C., N. L. Jones, P. J. Ceponis, M. A. Karmali, and P. M. Sherman. 2002. Escherichia coli Shiga-like toxins induce apoptosis and cleavage of poly(ADP-ribose) polymerase via in vitro activation of caspases. Infect. Immun. 70:4669-4677.
7. Corazza, N., D. Kassahn, S. Jakob, A. Badmann, and T. Brunner. 2009. TRAIL-induced apoptosis: between tumor therapy and immunopathology. Ann. N. Y. Acad. Sci. 1171:50-58.
8. Cory, A. H., T. C. Owen, J. A. Barltrop, and J. G. Cory. 1991. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun. 3:207-212.
9. Cummins, J. M., M. Kohli, C. Rago, K. W. Kinzler, B. Vogelstein, and F. Bunz. 2004. X-linked inhibitor of apoptosis protein (XIAP) is a nonredundant modulator of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human cancer cells. Cancer Res. 64:3006-3008. (Pubitemid 38581397)
10. DeLeo, F. R. 2004. Modulation of phagocyte apoptosis by bacterial pathogens. Apoptosis 9:399-413.
11. Elmore, S. 2007. Apoptosis: a review of programmed cell death. Toxicol. Pathol. 35:495-516.
12. Endo, Y., K. Tsurugi, T. Yutsudo, Y. Takeda, T. Ogasawara, and K. Igarashi. 1988. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur. J. Biochem. 171:45-50.
13. Erwert, R. D., R. K. Winn, J. M. Harlan, and D. D. Bannerman. 2002. Shiga-like toxin inhibition of FLICE-like inhibitory protein expression sensitizes endothelial cells to bacterial lipopolysaccharide-induced apoptosis. J. Biol. Chem. 277:40567-40574.
14. Fadok, V. A., D. R. Voelker, P. A. Campbell, J. J. Cohen, D. L. Bratton, and P. M. Henson. 1992. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148:2207-2216.
15. Faherty, C. S., and A. T. Maurelli. 2008. Staying alive: bacterial inhibition of apoptosis during infection. Trends Microbiol. 16:173-180.
16. Foster, G. H., and V. L. Tesh. 2002. Shiga toxin 1-induced activation of c-Jun NH(2)-terminal kinase and p38 in the human monocytic cell line THP-1: possible involvement in the production of TNF-alpha. J. Leukoc. Biol. 71: 107-114.
17. Fraser, M. E., M. M. Chernaia, Y. V. Kozlov, and M. N. G. James. 1994. Crystal structure of the holotoxin from Shigella dysenteriae at 2.5 Å resolution. Nat. Struct. Biol. 1:59-64.
18. Fujii, J., T. Matsui, D. P. Heatherly, K. H. Schlegel, P. I. Lobo, T. Yutsudo, G. M. Ciraolo, R. E. Morris, and T. Obrig. 2003. Rapid apoptosis induced by Shiga toxin in HeLa cells. Infect. Immun. 71:2724-2735.
19. Fulda, S. 2009. Caspase-8 in cancer biology and therapy. Cancer Lett. 281: 128-133.
20. Gong, B., and A. Almasan. 2000. Apo2 ligand/TNF-related apoptosis-inducing ligand and death receptor 5 mediate the apoptotic signaling induced by ionizing radiation in leukemic cells. Cancer Res. 60:5754-5760.
21. Green, D. R. 2000. Apoptotic pathways: paper wraps stone blunts scissors. Cell 102:1-4.
22. Harrison, L. M., R. P. Cherla, C. van den Hoogen, W. C. van Haaften, S.-Y. Lee, and V. L. Tesh. 2005. Comparative evaluation of apoptosis induced by Shiga toxin 1 and/or lipopolysaccharides in human monocytic and macrophage-like cells. Microb. Pathog. 38:63-76.
23. He, Q., D. I. Lee, R. Rong, M. Yu, X. Luo, M. Klein, W. S. El-Deiry, Y. Huang, A. Hussain, and M. S. Sheikh. 2002. Endoplasmic reticulum calcium pool depletion-induced apoptosis is coupled with activation of the death receptor 5 pathway. Oncogene 21:2623-2633. (Pubitemid 34478320)
24. Hietakangas, V., M. Poukkula, K. M. Heiskanen, J. T. Karvinen, L. Sistonen, and J. E. Eriksson. 2003. Erythroid differentiation sensitizes K562 leukemia cells to TRAIL-induced apoptosis by downregulation of c-FLIP. Mol. Cell. Biol. 23:1278-1291.
25. Huppi, K., S. E. Martin, and N. J. Caplen. 2005. Defining and assaying RNAi in mammalian cells. Mol. Cell 17:1-10. (Pubitemid 40075360)
26. Hymowitz, S. G., M. P. O'Connell, M. H. Ultsch, A. Hurst, K. Totpal, A. Ashkenazi, A. M. de Vos, and R. F. Kelley. 2000. A unique zinc-binding site revealed by a high-resolution X-ray structure of homotrimeric Apo2L/TRAIL. Biochemistry 39:633-640.
27. Jin, Z., and W. S. El-Deiry. 2005. Overview of cell death signaling pathways. Cancer Biol. Ther. 4:139-163.
28. Johansson, D., E. Kosovac, J. Moharer, I. Ljuslinder, T. Brannstrom, A. Johansson, and P. Behnam-Motlagh. 2009. Expression of verotoxin-1 receptor Gb3 in breast cancer tissue and verotoxin-1 signal transduction to apoptosis. BMC Cancer 9:e67.
29. Kim, Y., N. Suh, M. Sporn, and J. C. Reed. 2002. An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis. J. Biol. Chem. 277:22320-22329.
30. Kischkel, F. C., D. A. Lawrence, A. Chuntharapai, P. Schow, K. J. Kim, and A. Ashkenazi. 2000. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 12:611-620.
31. Kuang, A. A., G. E. Diehl, J. Zhang, and A. Winoto. 2000. FADD is required for DR4- and DR5-mediated apoptosis: lack of TRAIL-induced apoptosis in FADD-deficient mouse embryonic fibroblasts. J. Biol. Chem. 275:25065-25068.
32. Lee, J. H., J. Y. Jung, Y. J. Jeong, J. H. Park, K. H. Yang, N. K. Choi, S. H. Kim, and W. J. Kim. 2008. Involvement of both mitochondrial- and death receptor-dependent apoptotic pathways regulated by Bcl-2 family in sodium fluoride-induced apoptosis of the human gingival fibroblasts. Toxicology 243:340-347.
33. Lee, M.-S., R. P. Cherla, D. Leyva-Illades, and V. L. Tesh. 2009. Bcl-2 regulates the onset of Shiga toxin 1-induced apoptosis in THP-1 cells. Infect. Immun. 77:5233-5244.
34. Lee, S.-Y., R. P. Cherla, I. Caliskan, and V. L. Tesh. 2005. Shiga toxin 1 induces apoptosis in the human myelogenous leukemia cell line THP-1 by a caspase-8-dependent, tumor necrosis factor receptor-independent mechanism. Infect. Immun. 73:5115-5126.
35. Lee, S.-Y., R. P. Cherla, and V. L. Tesh. 2007. Simultaneous induction of apoptotic and survival signaling pathways in macrophage-like THP-1 cells by Shiga toxin 1. Infect. Immun. 75:1291-1302.
36. Lee, S.-Y., M.-S. Lee, R. P. Cherla, and V. L. Tesh. 2008. Shiga toxin 1 induces apoptosis through the endoplasmic reticulum stress response in human monocytic cells. Cell. Microbiol. 10:770-780.
37. Li, H., H. Zhu, C. J. Xu, and J. Yuan. 1998. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94:491-501. (Pubitemid 28391865)
38. Lingwood, C. A. 2003. Shiga toxin receptor glycolipid binding. Pathology and utility. Methods Mol. Med. 73:165-186.
39. MacFarlane, M., M. Ahmad, S. M. Srinivasula, T. Fernandes-Alnemri, G. M. Cohen, and E. S. Alnemri. 1997. Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL. J. Biol. Chem. 272:25417-25420.
40. Malhi, H., and G. J. Gores. 2006. TRAIL resistance results in cancer progression: a TRAIL to perdition? Oncogene 25:7333-7335.
41. Mariani, S. M., and P. H. Krammer. 1998. Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage. Eur. J. Immunol. 28:973-982.
42. Mead, P. S., L. Slutsker, V. Dietz, L. F. McCaig, J. S. Bresee, C. Shapiro, P. M. Griffin, and R. V. Tauxe. 1999. Food-related illness and death in the United States. Emerg. Infect. Dis. 5:607-625.
43. Moxley, R. A., and D. H. Francis. 1998. Overview of animal models, p. 249-260. In J. B. Kaper, A. D. O'Brien, (ed.), Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains. ASM Press, Washington, DC.
44. Ohmura, M., S. Yamasaki, H. Kurazono, K. Kashiwagi, K. Igarashi, and Y. Takeda. 1993. Characterization of non-toxic mutant toxins of Vero toxin 1 that were constructed by replacing amino acids in the A subunit. Microb. Pathog. 15:169-176.
45. Pitti, R. M., S. A. Marsters, S. Ruppert, C. J. Donahue, A. Moore, and A. Ashkenazi. 1996. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem. 271:12687-12690.
46. Proulx, F., and V. L. Tesh. 2007. Renal diseases in the pediatric intensive care unit: thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura, p. 1189-1204 In H. R. Wong, D. S. Wheeler, and T. P. Shanley (ed.), Pediatric critical care medicine: basic science and clinical evidence. Springer Verlag, London, United Kingdom.
47. Ramegowda, B., and V. L. Tesh. 1996. Differentiation-associated toxin receptor modulation, cytokine production, and sensitivity to Shiga-like toxins in human monocytes and monocytic cell lines. Infect. Immun. 64:1173-1180.
48. Sakiri, R., B. Ramegowda, and V. L. Tesh. 1998. Shiga toxin type 1 activates tumor necrosis factor-alpha gene transcription and nuclear translocation of the transcriptional activators nuclear factor-kappaB and activator protein-1. Blood 92:558-566.
49. Salhia, B., J. T. Rutka, C. Lingwood, A. Nutikka, and W. R. Van Furth. 2002. The treatment of malignant meningioma with verotoxin. Neoplasia 4:304-311.
50. Sandvig, K. 2001. Shiga toxins. Toxicon 39:1629-1635.
51. Saxena, S. K., A. D. O'Brien, and E. J. Ackerman. 1989. Shiga toxin, Shiga-like toxin II variant, and ricin are all single-site RNA N-glycosidases of 28 S RNA when microinjected into Xenopus oocytes. J. Biol. Chem. 264:596-601.
52. Schneider, P., M. Thome, K. Burns, J. L. Bodmer, K. Hofmann, T. Kataoka, N. Holler, and J. Tschopp. 1997. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. Immunity 7:831-836. (Pubitemid 28064896)
53. Sheikh, M. S., and Y. Huang. 2004. Death receptors as targets of cancer therapeutics. Curr. Cancer Drug Targets 4:97-104. (Pubitemid 38332568)
54. Shetty, S., J. B. Gladden, E. S. Henson, X. Hu, J. Villanueva, N. Haney, and S. B. Gibson. 2002. Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) up-regulates death receptor 5 (DR5) mediated by NFkappaB activation in epithelial derived cell lines. Apoptosis 7:413-420.
55. Strasser, A. 2005. The role of BH3-only proteins in the immune system. Nat. Rev. Immunol. 5:189-200.
56. Strockbine, N. A., L. R. M. Marques, J. W. Newland, H. Willams-Smith, R. K. Holmes, and A. D. O'Brien. 1986. Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities. Infect. Immun. 53:135-140.
57. Su, R. Y., K. H. Chi, D. Y. Huang, M. H. Tai, and W. W. Lin. 2008. 15-Deoxy-Delta12,14-prostaglandin J2 up-regulates death receptor 5 gene expression in HCT116 cells: involvement of reactive oxygen species and C/EBP homologous transcription factor gene transcription. Mol. Cancer Ther. 7:3429-3440.
58. Sugimoto, K., H. Toyoshima, R. Sakai, K. Miyagawa, K. Hagiwara, F. Ishikawa, F. Takaku, Y. Yazaki, and H. Hirai. 1992. Frequent mutations in the p53 gene in human myeloid leukemia cell lines. Blood 79:2378-2383.
59. Sun, S. Y., P. Yue, J. Y. Zhou, Y. Wang, H. R. Choi Kim, R. Lotan, and G. S. Wu. 2001. Overexpression of BCL2 blocks TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in human lung cancer cells. Biochem. Biophys. Res. Commun. 280:788-797.
60. Tarr, P. I., C. A. Gordon, and W. L. Chandler. 2005. Shiga-toxin- producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365:1073-1086. (Pubitemid 40386785)
61. Taylor, F. B., Jr., V. L. Tesh, L. DeBault, A. Li, A. C. K. Chang, S. D. Kosanke, T. J. Pysher, and R. L. Siegler. 1999. Characterization of the baboon responses to Shiga-like toxin: descriptive study of a new primate model of toxic responses to Stx-1. Am. J. Pathol. 154:1285-1299.
62. Tesh, V. L., J. A. Burris, J. W. Owens, V. M. Gordon, E. A. Wadolkowski, A. D. O'Brien, and J. E. Samuel. 1993. Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect. Immun. 61:3392-3402.
63. Thorburn, A. 2007. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) pathway signaling. J. Thorac. Oncol. 2:461-465.
64. Wang, Q., Y. Ji, X. Wang, and B. M. Evers. 2000. Isolation and molecular characterization of the 5′-upstream region of the human TRAIL gene. Biochem. Biophys. Res. Commun. 276:466-471.
65. Waterhouse, N. J., D. M. Finucane, D. R. Green, J. S. Elce, S. Kumar, E. S. Alnemri, G. Litwack, K. Khanna, M. F. Lavin, and D. J. Watters. 1998. Calpain activation is upstream of caspases in radiation-induced apoptosis. Cell Death Differ. 5:1051-1061. (Pubitemid 29008219)
66. Wiley, S. R., K. Schooley, P. J. Smolak, W. S. Din, C. P. Huang, J. K. Nicholl, G. R. Sutherland, T. D. Smith, C. Rauch, C. A. Smith, and R. G. Goodwin. 1995. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673-682.
67. Wu, G. S. 2009. TRAIL as a target in anti-cancer therapy. Cancer Lett. 285:1-5.
68. Yamaguchi, H., and H. G. Wang. 2004. CHOP is involved in endoplasmic reticulum stress-induced apoptosis by enhancing DR5 expression in human carcinoma cells. J. Biol. Chem. 279:45495-45502.